Develops trans-catheter systems for treating mitral regurgitation linked to congestive heart failure.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Ancora Heart develops percutaneous trans-catheter mitral annuloplasty systems for the treatment of mitral regurgitation associated with Congestive Heart Failure.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Ancora Heart Management Team
Investors
New Enterprise Associates Inc (NEA)
Savitr Capital
Ancora Heart Valuations & Financials
View real-time NPM data on Ancora Heart stock including daily Ancora Heart stock price estimates, valuation history, and historical share price information. Access Ancora Heart financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Ancora Heart pricing across six independent market signals. Looking for private company due diligence data sources on Ancora Heart? Get in touch to learn more.
Similar Companies
like Ancora Heart
Sampling Human
Healthcare & Life Sciences
Biotech company developing cell-based diagnostic tools for early disease detection with higher sensitivity and speed than traditional methods.
TPA Stream
Healthcare & Life Sciences
Automates claims, invoicing, and communications to streamline administrative workflows.
Orthogon Therapeutics
Healthcare & Life Sciences
Develops therapies for challenging drug targets using structure-based design and biophysics to create innovative treatment solutions.
Jump Technologies
Healthcare & Life Sciences
Provides cloud‑based inventory visibility and analytics to streamline workflows and reduce waste.
GeneCentric Therapeutics
Healthcare & Life Sciences
Utilizes a unique partnership model to translate important cancer discoveries into clinically adopted diagnostics for pathologists, clinicians, and patients.
Aneira Pharma
Healthcare & Life Sciences
Develops innovative hair growth solutions and formulations to stimulate regrowth and thickness, targeting both male and female consumers.
Hello Alpha
Healthcare & Life Sciences
On‑demand virtual healthcare platform specializing in comprehensive, asynchronous primary care for individuals.
Unnatural Products
Healthcare & Life Sciences
Develops which macrocyclic compounds emulate natural molecules to reach challenging targets through AI-guided design and synthesis.
Procyrion
Healthcare & Life Sciences
Develops a catheter-deployed circulatory support device to reduce cardiac workload and enhance renal perfusion in heart failure patients.
FAQ
We have answers
Ancora Heart stock does not trade on public stock exchanges. Ancora Heart stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Ancora Heart stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Ancora Heart Stock does not trade on public stock exchanges. In order to sell Ancora Heart shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Ancora Heart does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Ancora Heart share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Ancora Heart stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Ancora Heart stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Ancora Heart stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Ancora Heart is a private company and has not had an IPO. There is currently no Ancora Heart IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Ancora Heart IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
